Cardiac Resynchronization Therapy in Women

Area of Science:

• Cardiology
• Medical Devices

Background:

• Cardiac resynchronization therapy (CRT) is crucial for heart failure management.
• Women are underrepresented in clinical trials for CRT devices.
• Existing data suggest women experience greater clinical benefits from CRT compared to men.

Purpose of the Study:

• To evaluate the efficacy of CRT in women with heart failure.
• To investigate the optimal QRS duration criteria for CRT prescription in women.
• To address the underrepresentation of women in CRT research.

Main Methods:

• Analysis of existing clinical trial data focusing on CRT outcomes in female patients.
• Comparison of CRT response rates between men and women across various QRS durations.
• Examination of the prevalence of left bundle branch block in women undergoing CRT.

Main Results:

• Women demonstrate a high CRT response rate (90%) across a broad QRS duration range (130-175 milliseconds).
• Women are more frequently diagnosed with left bundle branch block, a key indicator for CRT.
• A QRS duration threshold of 150 milliseconds may exclude women who would benefit from CRT.

Conclusions:

• The current QRS duration threshold for CRT may be suboptimal for female patients.
• Expanding CRT eligibility criteria to include a wider range of QRS durations in women could improve outcomes.
• Further research is needed to optimize CRT delivery for female heart failure patients.